Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975 Dec 31;45(2):221-4.
doi: 10.1007/BF00429064.

LSD as an agonist at mesolimbic dopamine receptors

P H Kelly, L L Iversen

LSD as an agonist at mesolimbic dopamine receptors

P H Kelly et al. Psychopharmacologia. .

Abstract

The dopamine agonist apomorphine (1.0 mg/kg i.p.) produced an enhanced stimulation of locomotor activity compared to control animals in rats injected bilaterally 14 days previously with 6-hydroxydopamine (6OHDA) into the nucleus accumbens. (+)-Lysergic acid diethylamide (LSD) also produced a marked stimulation of locomotor activity in the 6OHDA treated animals at a dose (1.0 mg/kg i.p.) which was ineffective in control rats. (+)-Bromo-lysergic acid diethylamide (2.0 mg/kg i.p.) did not stimulate locomotor activity in 6OHDA treated rats. The locomotor stimulation produced by LSD was blocked by pretreatment with the dopamine antagonist pimozide (0.5 mg/kg i.p.). It is suggested that LSD acts as an agonist at mesolimbic dopamine receptors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. AMA Arch Neurol Psychiatry. 1957 Apr;77(4):350-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1972 Aug;69(8):2145-9 - PubMed
    1. Psychopharmacologia. 1967;11(2):179-93 - PubMed
    1. J Neurochem. 1973 Aug;21(2):477-9 - PubMed
    1. Brain Res. 1970 Dec 18;24(3):485-93 - PubMed

LinkOut - more resources